• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconThe Capsule

The Capsule

0
David Feinberg photo
NewslettersGoogle Health is being dismantled, but Big Tech’s quixotic health ambitions persist
By Sy MukherjeeAugust 26, 2021
COVID vaccine booster shot DIY mix and match
NewslettersAnother COVID booster unknown: Will more doses for the vaccinated cause new variants?
By Sy MukherjeeAugust 19, 2021
There are no authorized COVID booster shots. More than one million Americans have gotten them anyway
NewslettersThere are no authorized COVID booster shots. More than one million Americans have gotten them anyway
By Sy MukherjeeAugust 12, 2021
Moderna earnings vaccines stock
NewslettersModerna’s unlikely journey to rivaling Big Pharma giants’ valuations
By Sy MukherjeeAugust 5, 2021
CDC masking indoor businesses Apple
NewslettersOffices, employees, and customers: The COVID mask conundrum
By Sy MukherjeeJuly 29, 2021
An health care worker administers a jab containing Pfizer vaccine on a caregiver of the SAVF Evanna Tehuis old age home near Klerksdorp, South Africa, on May 19, 2021.
NewslettersAfrica’s first mRNA vaccine production deal has finally appeared
By David MeyerJuly 22, 2021
Covid vaccines
NewslettersCOVID vaccines, variants, and boosters are a nuanced storm
By Sy MukherjeeJuly 15, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
NewslettersThe never ending Biogen Alzheimer’s drug saga delivers yet another twist
By Sy MukherjeeJuly 8, 2021
CRISPR Gene Editing Cancer Safety
NewslettersThe CRISPR breakthrough that can change the future of gene editing
By Sy MukherjeeJuly 1, 2021
COVID Delta Delta plus variants
NewslettersThe delta between the Delta variants
By Sy MukherjeeJune 24, 2021
Juneteenth Black diversity officers health inequality
NewslettersThree Black health care diversity officers. One united goal
By Sy MukherjeeJune 17, 2021
Biogen aducanumab FDA approval
NewslettersWhat comes next after the Biogen Alzheimer’s drug approval
By Sy MukherjeeJune 10, 2021
New Fortune 500 CEOS 2021
NewslettersThe health care companies leading 2021’s Fortune 500 list
By Sy MukherjeeJune 3, 2021
Abortion, Obamacare, and drug approvals: American health care faces a pivotal moment
NewslettersAbortion, Obamacare, and drug approvals: American health care faces a pivotal moment
By Sy MukherjeeMay 27, 2021
Pharmaceutical Executives Testify At Senate Finance Committee Hearing On Drug Prices
NewslettersCongress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?
By Sy MukherjeeMay 20, 2021
0
Most Popular
Economy
Jerome Powell says the $39 trillion national debt is ‘not unsustainable,’ but warns the trajectory ‘will not end well’placeholder alt text
By Fortune EditorsMarch 30, 2026
Success
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strainplaceholder alt text
By Fortune EditorsMarch 31, 2026
AI
A man used AI to call 3,000 Irish bartenders to track the cost of Guinness. Now pubs are lowering their prices to competeplaceholder alt text
By Fortune EditorsMarch 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.